Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Immunic, Inc. (IMUX) common stock is covered by amended beneficial-ownership reports from OrbiMed Advisors LLC, OrbiMed Genesis GP LLC and OrbiMed Capital LLC. Advisors and Genesis each reported 314,409 shares, or 2.3%, with shared voting and dispositive power; Capital reported 161,395 shares, or 1.2%, with sole voting and dispositive power. The reporting persons said they held 3.5% of the common stock on behalf of other persons entitled to direct dividends or sale proceeds. Carl L. Gordon, W. Carter Neild and Geoffrey C. Hsu serve on the management committee exercising investment and voting power, and each disclaims beneficial ownership of the reported shares.
Key Figures
Beneficial ownership — OrbiMed Advisors LLC:314,409 sharesBeneficial ownership — OrbiMed Genesis GP LLC:314,409 sharesBeneficial ownership — OrbiMed Capital LLC:161,395 shares+1 more
4 metrics
Beneficial ownership — OrbiMed Advisors LLC314,409 shares2.3% of the class; shared voting and dispositive power
Beneficial ownership — OrbiMed Genesis GP LLC314,409 shares2.3% of the class; shared voting and dispositive power
Beneficial ownership — OrbiMed Capital LLC161,395 shares1.2% of the class; sole voting and dispositive power
Shares held on behalf of other persons3.5%The reporting persons said the other persons could direct dividends or sale proceeds
Key Terms
Beneficially Owned, Shared Voting Power, Shared Dispositive Power
3 terms
Beneficially Ownedregulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Powerregulatory
"Shared Voting Power 314,409.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 314,409.00"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many IMUX shares did OrbiMed report owning?
OrbiMed Advisors LLC and OrbiMed Genesis GP LLC each reported beneficial ownership of 314,409 shares, or 2.3%. OrbiMed Capital LLC reported 161,395 shares, or 1.2%.
What percentage of IMUX shares did OrbiMed hold for other investors?
The reporting persons said they held 3.5% of Immunic common stock on behalf of other persons who had the right to receive or direct dividends or sale proceeds.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Immunic, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
4525EP101
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
4525EP101
1
Names of Reporting Persons
OrbiMed Advisors LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
314,409.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
314,409.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
314,409.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.3 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
4525EP101
1
Names of Reporting Persons
OrbiMed Genesis GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
314,409.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
314,409.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
314,409.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
4525EP101
1
Names of Reporting Persons
OrbiMed Capital LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
161,395.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
161,395.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
161,395.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.2 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Immunic, Inc.
(b)
Address of issuer's principal executive offices:
1200 Avenue of the Americas, Suite 200, New York, NY 10036
Item 2.
(a)
Name of person filing:
OrbiMed Advisors LLC
OrbiMed Genesis GP LLC
OrbiMed Capital LLC
(b)
Address or principal business office or, if none, residence:
601 Lexington Avenue, 54th Floor, New York, NY 10022
(c)
Citizenship:
Please refer to Item 4 on each cover sheet for each filing person.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
4525EP101
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
OrbiMed Advisors LLC: 314,409
OrbiMed Genesis GP LLC: 314,409
OrbiMed Capital LLC: 161,395
(b)
Percent of class:
OrbiMed Advisors LLC: 2.3%
OrbiMed Genesis GP LLC: 2.3%
OrbiMed Capital LLC: 1.2%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
OrbiMed Advisors LLC: 0
OrbiMed Genesis GP LLC: 0
OrbiMed Capital LLC: 161,395
(ii) Shared power to vote or to direct the vote:
OrbiMed Advisors LLC: 314,409
OrbiMed Genesis GP LLC: 314,409
OrbiMed Capital LLC: 0
(iii) Sole power to dispose or to direct the disposition of:
OrbiMed Advisors LLC: 0
OrbiMed Genesis GP LLC: 0
OrbiMed Capital LLC: 161,395
(iv) Shared power to dispose or to direct the disposition of:
OrbiMed Advisors LLC: 314,409
OrbiMed Genesis GP LLC: 314,409
OrbiMed Capital LLC: 0
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
The Reporting Persons hold 3.5% of the shares of Common Stock in the aggregate on behalf of other persons who have the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, such securities. OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC exercise investment and voting power over the shares of Common Stock through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares of Common Stock reported herein.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.